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Importin 13The constitutive androstane receptor (CAR) is a member of the nuclear receptor superfamily. The CAR is
normally located in the cytoplasmic compartment of untreated liver cells and translocates to the nucleus
after exposure to phenobarbital (PB) or PB-like chemicals. Previously, we identiﬁed two nuclear localization
signals (NLS) in the rat constitutive androstane/active receptor (CAR), NLS1, which is located in the hinge
region, and NLS2, which overlaps with the ligand-binding domain. However, the nuclear import mechanism
of CAR is unclear. In this study, we show that nuclear import of CAR is regulated by importin/Ran-GTP
systems. The regulation of CAR nuclear import by a Ran-GTP concentration gradient was conﬁrmed using the
dominant negative, GTPase-deﬁcient form of Ran (RanQ69L), suggesting the involvement of transport
receptors of the importinβ family. IPO13 was shown to be involved in the PB-mediated nuclear translocation
of CAR, which was found to be susceptible to inhibition by a dominant negative mutant of IPO13 in primary
hepatocytes.receptor; XRS, xenochemical
omplexes; IPO13, importin 13;
al; GR, glucocorticoid receptor;
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Proteins and RNA enter and exit the nucleus through nuclear
pore complexes (NPC) in the nuclear envelope. Small molecules
readily diffuse through nuclear pores; whereas, molecules with
molecule weights greater than ∼40 kDa undergo energy-dependent
transport, which requires import and export machinery and
depends on the Ran GTPase system [1–4]. The ﬁrst nuclear
localization signal (NLS) was identiﬁed in the SV40 large T-antigen
[5]. Later, two proteins that import substrates containing SV40 NLS
(NLSSV40)-like domains were identiﬁed: importinα (IPOα), which
binds to the NLS of its substrate as an adaptor, and transport
receptor importinβ (IPOβ), which binds to IPOα, creating a trimeric
complex that imports the substrate into the nucleus through NPC
[6]. In general, classical NLS as represented by NLSSV40, which are
categorized into monopartite and bipartite NLS, are recognized by
IPOα, which is in turn recognized by IPOβ. Based on their similarity
to IPOβ, nuclear import and export receptors, which are collectively
referred to as the importinβ family (they are also called the
karyopherin β family), were identiﬁed. However, many importinβ
proteins bind directly to their cargoes and do not rely on adaptors.These proteins have been shown to transport a wide variety of
proteins and RNA [7] in and out of the nucleus by recognizing NLS
and nuclear export signals (NES), respectively.
The nuclear receptor superfamily consists of ligand-dependent
transcription factors, including receptors for steroid hormones,
thyroid hormones, retinoic acid, and vitamin D, and also numerous
orphan receptors. Although nuclear receptors, such as the gluco-
corticoid receptor (GR) and androgen receptor (AR), are localized to
the cytoplasm [8], the estrogen receptor and progesterone receptor
are constitutively nuclear [9,10]. Steroid receptors are actively
shuttled between the nucleus and the cytoplasm, even in the
absence of their ligands, and this shuttling depends on NLS and
NES, as described above. Therefore, the subcellular localization of
steroid receptors is determined, at least in part, by the balance
between the rates of their nuclear import and export [11].
Alternatively, GR and AR may be tethered to a cytoplasmic factor
or complexed in the absence of hormones. Pratt et al. demonstrated
that components of the apoGR complex bind to cytoskeletal factors
[11,12], and three NLS in the amino terminal transactivation
domain (NTD), DNA binding domain (DBD), and ligand-binding
domain (LBD) of AR have had their import abilities assessed. Those
in the NTD and DBD showed ligand-independent nuclear import
abilities; whereas, the NLS in the LBD demonstrated ligand-
dependent transport ability [13–15]. In addition, an AR deletion
mutant lacking the DBD was found to be distributed in the
cytoplasm regardless of the presence or absence of ligands,
suggesting that the remaining domains, NTD and LBD, are
responsible for the cytoplasmic localization of AR [16].
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cluster of basic amino acids in a sequence similar to NLSSV40 located
in the C-terminal region of the DBD, and NL2 is a poorly deﬁned NLS
that is widely distributed throughout the LBD [17–19]. The nucleo-
cytoplasmic trafﬁcking of unliganded GR reﬂects the binding of
importinα to the NL1 in hsp90-complexed receptors and the export of
GR from the nucleus through a CRM1-dependent pathway [20]. In
contrast to GR, −NL1-GR, an NL1-defective mutant of GR, demon-
strated an entirely cytoplasmic localization following leptomycin B
treatment, further supporting the conclusion that the nuclear import
of unliganded GR is entirely NL1-dependent.
Following hormone binding, GR translocates to the nucleus,
while steroid withdrawal facilitates its export from the nucleus.
Previous reports have suggested that the nuclear import of GR is
regulated by IPOα/β, importin 7 (IPO7) [21], and importin 13
(IPO13) [22]. IPO13, the latest member of the importinβ family to
be discovered, is a unique nucleus–cytoplasm bidirectional transport
receptor that is involved in cell development and physiologic
functions such as embryonic development of the lungs, brain, and
heart [23,24]. These import receptors were found to bind to GR
prior to hormone binding, implying that hormonal control of
intracellular localization is exerted downstream of import receptor
binding. NL1 is dependent on both Ran GTPase and IPO α/β−;
whereas, NL2 is also Ran GTPase-dependent but does not require
IPOα/β. The NL2-mediated nuclear import of GR occurs slower than
translocation via NL1 and is hormone-dependent. Among the
nuclear import receptors reported to be involved in the nuclear
translocation of GR, IPO7 and IPO13 are considered to be
responsible for its hormone-dependent nuclear import. Thus, the
nuclear import of GR might be accomplished by multiple transport
receptors, providing an opportunity for context-speciﬁc regulation.
For example, it was hypothesized that the hormonal, temporal, and
spatial regulation of IPO13 would reﬂect the need for the subcellular
localization of developmentally regulated cargo substrates, and it
was found that intracellular levels of IPO13 and intracellular IPO13
shuttling rates may contribute to glucocorticoid resistance in
common disorders such as asthma [25].
The constitutive active/androstane receptor (CAR), a member of
the nuclear hormone receptor superfamily consisting of 358 amino
acid residues, is a transcription factor that regulates gene expression
in response to structurally divergent compounds, such as environ-
mental pollutants and endogenous metabolites. CAR regulates the
expression of a variety of genes including those involved in the
hepatic metabolism of xenobiotics, especially the cytochrome P450
2B, 2C, and 3A subfamilies; various conjugation enzymes; and
membrane transporters.
CAR is normally sequestered into the cytoplasmic compartment
of untreated liver cells and translocated to the nucleus after exposure
to phenobarbital (PB) or PB-like chemicals. The cytoplasmic CAR
retention protein has been reported to maintain the level of CAR in
the cytoplasm by forming a complex with heat shock protein 90
[26,27]. Following nuclear translocation, CAR binds to response
elements in the promoter regions of its target genes, forming a
heterodimer with retinoid X receptor α [28]. A leucine-rich sequence
near the C-terminal region of CAR called the xenochemical response
signal (XRS) was identiﬁed as an essential motif for PB-mediated
nuclear translocation of CAR in the liver and primary hepatocytes
[29,30]. However, the XRS motif does not contain a classical NLS.
Previously, we identiﬁed the subcellular localization signals of rat
CAR (rCAR). rCAR has two NLS, two NES, and a cytoplasmic retention
region (CRR) [30–32]. The monopartite NLS (named NLS1) is located
in the hinge region, and the other NLS is an assembly of
noncontiguous signals (named NLS2) within the LBD. However, the
nuclear transport mechanism of CAR remains unclear. Here, we show
that IPO13 interacts with CAR and regulates PB-mediated nuclear
translocation of CAR.2. Material and methods
2.1. Cell culture
COS-7 cells were grown in Dulbecco's modiﬁed Eagle's medium
supplemented with 10% fetal bovine serum, penicillin, and strepto-
mycin at 37 °C in a humidiﬁed atmosphere containing 5% CO2. The
hepatocytes used for the primary culture were obtained from the
livers of 6-week-old male Wistar rats (Clea) using the collagenase
perfusion method. After enumeration of the cells by Trypan blue dye
exclusion, the hepatocytes were cultured in WE medium supplemen-
ted with 10% fetal bovine serum. Four hours after plating, the medium
was exchanged for WE medium containing 10−8 M Dex.
2.2. Plasmid construction
The construction of the pEGFP-rCAR plasmid has been described
previously [30]. FLAG-tagged CAR expression plasmids, pFLAG-rCAR
(1–358), pFLAG-rCAR DBD(1–110), and pFLAG-rCAR LBD(111–358)
were subcloned into the pCMV-3Tag6 vector (Stratagene) by anchor
PCR using speciﬁc primers and pEGFP-rCAR as a template, as
described previously. The expression plasmid for GST-fusion protein
was constructed by subcloning the ampliﬁed rCAR LBD(111–358)
sequence into the pGEX-4T1 vector (GE healthcare). The expression
plasmid for full-length IPO13 was prepared by subcloning the coding
sequence, which was ampliﬁed according to the standard PCR
method, into a myc-tag-containing pcDNA5/TO (Invitrogen) plasmid.
The coding sequences for the deletion mutants IPO13(1–963), IPO13-
N(1–488), and IPO13-C(481–963) were subcloned into the myc-tag
containing pcDNA5/TO plasmid by anchor PCR using speciﬁc primers
and the full-length IPO13 expression plasmid as a template. The
expression plasmid for monomer Kusabira Orange (mKO)-tagged
IPO13-C was constructed by replacing the myc-tag with the mKO
sequence from the pmKO1-S1 plasmid in the myc-tagged IPO13-C-
expressing plasmid constructed from the pcDNA5/TO background.
The expression plasmid for mKO-Ran was prepared by subcloning the
coding sequence for Ran, which was ampliﬁed according to the
standard PCR method, into the mKO-tag-containing-pcDNA5/TO
plasmid and that for mKO-tagged RanQ69L, which is a GTPase-
deﬁcient Ran mutant that remains GTP-bound in the presence of
cytoplasmic Ran GTPase-activating protein (RanGAP1) [33], was
constructed using the QuickChange Site-directed Mutagenesis Kit
(Stratagene) and speciﬁc primers. The expression plasmids for GST-
fusion proteins were constructed by subcloning the ampliﬁed Ran or
RanQ69L sequence into the pGEX-4T1 vector.
Transfection and ﬂuorescence visualization by confocal laser-
scanning microscopy COS-7 cells were seeded in 4-well chambered
coverglasses (IWAKI). The cells were then transfectedwith the pEGFP-
rCAR and pmKO-RanQ69L plasmids using the GeneJuice transfection
reagent (Novagen). In the case of the rat primary hepatocytes, the cells
were seeded in 4-well collagen-coated chambered coverglasses
(IWAKI). The cells were then transfected with the pEGFP-rCAR and
pmKO-IPO13-C plasmids on the day of plating using the TransFectin
Transfection Reagent (BIO-RAD). After overnight incubation, the cells
were treated with 1 mM PB for 6 h, and then the intracellular
expression proﬁles of the GFP-rCAR chimeric proteins were observed
with a Zeiss LSM 510. The cells were then fractionated into 3
categories based on their subcellular distribution of ﬂuorescence
signals as follows: a predominantly nuclear distribution (NNC), even
distribution between the cytoplasm and nucleus (N=C), and a
predominantly cytoplasmic distribution (NbC).
2.3. GST pull-down assay
Glutathione-S-transferase-Ran fusion protein (GST-Ran) and GST-
RanQ69L were overexpressed in E. coli BL21 cells and then allowed to
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were released from the beads by cleavage with thrombin. Then, these
puriﬁed Ran proteins were loaded with either 2 mM GDP or GTP inFig. 1. Effect of the disruption of the Ran-GTP system on the nuclear import of CAR. (A) COS-7
mutant of mKO-Ran. Twenty-four hours after the transfection, the cells were observed u
ﬂuorescence-positive cells was conducted based on the subcellular distribution of the ﬂuo
(NNC), ﬂuorescence evenly distributed between the cytoplasm and nucleus (N=C), and p50 mMHEPES-NaOH (pH 7.3), 200 mMNaCl, 5 mMMgCl2, and 1 mM
DTT at room temperature for 2 h. Next, 50 mM MgCl2 were added,
and the mixture was incubated at 4 °C for 20 min to stop the loading.cells were cotransfected with GFP-rCAR andmKO ormKO-RanQ69L, a GTPase-deﬁcient
sing a confocal laser-scanning microscope. Bar: 10 μm. (B) Fractionation analysis of
rescence signal. The cells were scored as follows: predominantly nuclear ﬂuorescence
redominantly cytoplasmic ﬂuorescence (NbC).
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transfected with the pGro7/BL21 plasmid (TAKARA) and allowed to
bind to glutathione Sepharose 4B beads. The myc-IPO13-over-
expressed COS-7 cell lysate was then mixed with the GST-rCAR
LBD-bound beads and incubated at 4 °C for 2 h. To investigate the
effect of Ran-GTP or Ran-GDP on the binding of IPO13 to CAR, the
mixture was separated into two tubes and fed with Ran-GTP or
Ran-GDP. After being washed, the beads were mixed with SDS-
PAGE sample buffer, and then the whole mixture was processed by
SDS-PAGE and Western blotting using anti-myc and anti-GST
antibodies.Fig. 2. Protein–protein interactions between CAR and IPO13. (A) Deletion mutants of CAR (a
the expression plasmid for FLAG-rCAR WT or its mutants, and myc-IPO13 or its mutants. W
coprecipitants were resolved by SDS-PAGE and detected by Western blot analysis using an2.4. Coimmunoprecipitation analysis
COS-7 cells were seeded in 60-mm plates containing DMEM
supplementedwith 10% FBS and transfectedwith expression plasmids
using the GeneJuice transfection reagent. After 48 h, the cells were
harvested after being washed twice with ice-cold PBS and suspended
in lysis buffer (50 mM Tris–HCl, 1 mM EDTA, 150 mM NaCl, and 1%
Triton X-100) containing protease inhibitor cocktail (Roche). Next, the
supernatants were incubated with anti-FLAG M2 agarose (SIGMA) at
4 °C for 2 h. Then, the beads were washed three times with wash
buffer (50 mMTris–HCl, 1 mMEDTA, 650 mMNaCl, and 0.1% Triton X-) and IPO13 (b) are schematically illustrated. (B, C) COS-7 cells were cotransfected with
hole cell extracts were then coimmunoprecipitated using anti-FLAG M2 agarose. The
ti-myc and anti-FLAG antibody.
Fig. 3. Binding of IPO13 to CAR in the presence of Ran-GTP or Ran-GDP. GST-CAR LBD-
bound to glutathione. Sepharose 4B beads were incubated with myc-IPO13 over-
expressing COS-7 cell lysate in the presence of Ran-GTP or Ran-GDP. The binding of
myc-IPO13 to GST-CAR LBD was detected by SDS-PAGE Western blotting using anti-
myc and anti-GST antibodies.
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tated proteins were then separated by SDS-PAGE and Western blot
analysis using anti-myc antibody (MBL) and anti-FLAG M2 antibody
(SIGMA).
3. Results
3.1. Nuclear import of CAR is regulated by Ran-GTP systems
Proteins and RNA enter and exit the nucleus through nuclear
pores. Small molecules are transported by passive diffusion; however,
molecules with a molecular weight of greater than 20–40 kDa have to
undergo energy-dependent transport, which requires import and
export machinery and is dependent on Ran GTPase. Previously, we
identiﬁed two NLS in CAR. To clarify the mechanism of the regulation
of the nuclear import of CAR by the Ran-GTP concentration gradient,
we carried out an import inhibition assay using the dominant
negative, GTPase-deﬁcient form of Ran (RanQ69L) [33]. COS-7 cells
were transfected with expression vectors for GFP-CAR (green
ﬂuorescence) alone or simultaneously with mKO-RanQ69L (red
ﬂuorescence) expression vectors. The representative intracellular
localization patterns of GFP and mKO that were observed with
confocal laser-scanning microscopy are shown in Fig. 1A, and the
fractional distribution percentages are shown in Fig. 1B. The nuclearFig. 4. C-terminal fragment of IPO13 blocks PB-mediated nuclear translocation of CAR. Ra
incubated overnight. After the cells had been treated with 1 mM PB for 6 h, they were observ
are marked by arrows.accumulation of GFP-CAR was observed in COS-7 cells, in accordance
with the ﬁndings of a previous report that demonstrated that CARwas
spontaneously translocated into the nucleus in a cultured cell line
[31,35]. The inhibition of the nuclear import of GFP-CARwas observed
after its cotransfection with mKO-RanQ69L, while the overexpression
of wild type Ran (mKO-Ran) did not affect the subcellular distribution
of GFP-CAR. Based on these results, the nuclear import of CAR might
depend on the Ran-GTP system, suggesting the involvement of a
member of the importinβ family.
3.2. IPO13 interacts with the LBD of CAR as a cargo
Previously, the nuclear import of GR was reported to be mediated
by IPO13 [22]. IPO13 binds to full-length GR and NL1-GR, which is an
NL1-defective mutant of GR, suggesting that IPO13 binds to the NL2 of
GR. As NLS2 is an assembly of noncontiguous amino acid residues that
is distributed widely throughout the LBD, similar to the NL2 of GR, we
speculated that IPO13 is involved in the nuclear import of CAR. To
investigate this, we examined whether IPO13 interacted with CAR
using an immunoprecipitation assay. FLAG-tagged rCAR (FLAG-rCAR)
and myc-tagged IPO13 (myc-IPO13) were cotransfected into COS-7
cells, and immunoprecipitation was carried out using anti-FLAG M2
agarose. As a result, coprecipitation of myc-IPO13 with CAR was
detected by Western blot analysis using anti-myc antibody (Fig. 2B,
lane 2). Furthermore, the interaction of CAR with IPO13 was
investigated using two FLAG-tagged CAR deletion mutants, FLAG-
rCAR DBD and FLAG-rCAR LBD (C-terminally truncated rCAR contain-
ing NLS1 and N-terminally truncated rCAR containing NLS2, respec-
tively). Coprecipitation with myc-IPO13 was observed for FLAG-rCAR
LBD but not FLAG-rCAR DBD (Fig. 2B, lanes 3 and 4, respectively).
Next, we attempted to locate the region of IPO13 that bindswith rCAR.
It has been reported that the N-terminal region of IPO13 (IPO13-N) is
essential for cargo nuclear import and Ran-GTP binding, while the C-
terminal region (IPO13-C) binds to the cargo. The immunoprecipita-
tion study demonstrated the interaction of rCAR with IPO13-C
(Fig. 2C). These results suggest that rCAR is a cargo of IPO13 and
that IPO13 binds to the NLS2 of rCAR. IPO13 has been reported to
function as both a nuclear import and an export receptor. The binding
of Ran-GTP to IPO13 causes it to release its cargo from the import
complex and promotes the binding of distinct cargoes to the export
complex. Therefore, we investigated the effect of Ran-GTP binding on
the interaction between rCAR and IPO13. We carried out GST pull-
down assays in the presence of Ran-GDP or Ran-GTP, in whicht primary hepatocytes were transfected with GFP-rCAR and mKO or mKO-IPO13 and
ed with a confocal laser-scanning microscope. The cells that coexpressed GFP and mKO
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an interaction between GST-CAR LBD and IPO13 was observed (Fig. 3,
lane 3). Ran-GTP reduced the interaction between GST-CAR LBD and
IPO13 more potently than Ran-GDP (Fig. 3, lanes 3 and 4). Similar
results were obtained with GR, which is known to be a cargo of IPO13
(Fig. S1). Thus, CAR is released from IPO13 in the presence of Ran-GTP,
suggesting that CAR is an import cargo of IPO13. PB-mediated nuclear
translocation of CAR is blocked by a C-terminal dominant negative
mutant of IPO13. In primary hepatocytes, CAR translocates to the
nucleus from the cytoplasm after PB treatment. Therefore, we
investigated whether PB-mediated nuclear translocation of CAR
could be blocked by a dominant negative mutant of IPO13 in primary
hepatocytes. The C-terminal fragment of the dominant negative
mutant of IPO13 is known to bind to its cargo but does not show
nuclear import activity. We expressed GFP-rCAR in the presence of
mKO ormKO-fusedwith IPO13-C (mKO-IPO13-C). After PB treatment,
the nuclear translocation of GFP-rCARwas observed in the presence of
mKO (Fig. 4 left), while no PB-mediated nuclear translocation of GFP-
rCAR was observed in the presence of the dominant negative mutant,
mKO-IPO13-C (Fig. 4 right). Furthermore, no reduction in the PB-
mediated nuclear translocation of GFP-rCARwas observedwhen short
hairpin RNA of IPO13 was cotransfected with the GFP-rCAR (Fig. S2),
suggesting the existence of other importin(s) that compete for the
NLS2 of rCAR. These ﬁndings suggest that IPO13 acts as a regulator of
PB-mediated nuclear translocation of CAR in primary hepatocytes.
4. Discussion
CAR is normally sequestered into the cytoplasmic compartment of
untreated liver cells. After stimulation with activators, CAR translo-
cates into the nucleus and transactivates the expression of target
genes. Thus, nuclear translocation is the ﬁrst step of CAR activation.
In this study, we demonstrated for the ﬁrst time that CAR was
imported into the nucleus by a combination of importin and Ran-GTP
systems. We showed that disruption of the Ran-GTP system inhibits
the nuclear import of CAR and that CAR interacts with IPO13.
Furthermore, the blockade of PB-mediated nuclear translocation by
a C-terminal fragment of IPO13 carrying the cargo-binding region
suggests that PB-mediated nuclear import is regulated by IPO13 in
vivo.
Previous studies have identiﬁed other cargos of IPO13 including an
import carrier for UBC9, MGN, paired homeodomain transcription
factor Pax-6 [36], actin binding protein myopodin, and nuclear
receptor GR [22,34,37]. In addition to these monomeric substrates,
IPO13mediates the nuclear import of the heterodimeric NF-YB/NF-YC
complex of transcriptional factor NF-Y and the human histone fold
pairs CHRAC-15/CHRAC-17 and p12/CHRAC-17 [38,39].
GR belongs to the nuclear receptor superfamily, as does CAR. IPO13
imports full-length GR as well as the NL1-abolished mutant of GR,
suggesting that IPO13 binds to NL2. Both the NL2 of GR and the NLS2
of CAR are poorly deﬁned NLS that are widely distributed throughout
the LBD region [20,30]. As in the case of GR, the NLS2 of CAR appears to
be recognized by IPO13 because IPO13 binds to the LBD of CAR. We
previously outlined the species-speciﬁc differences in NLS between
human CAR (which consists of 348 amino acids) and rat CAR (which
consists of 358 amino acids) [31,32]. hCAR lacks a functional NLS1,
owing to a single amino acid change in NLS1 from Arg106 to Glu116.
However, PB-mediated nuclear translocation is observed in both
exogenously expressed hCAR and rCAR in rat primary hepatocytes.
Thus, we consider that NLS2 is crucial for PB-mediated nuclear
translocation of CAR. We observed that PB-mediated nuclear
translocation of GFP-rCAR was blocked when it was coexpressed
with the dominant negative C-terminal fragment of IPO13, supporting
the pivotal role of NLS2 in PB-responsive nuclear transport of CAR.
However, PB-dependent nuclear translocation of CAR was not
inhibited by knockdown of IPO13. Taken together, our results suggestthat IPO13 plays a partial role in the nuclear import of CAR and that
the nuclear import of CAR is performed by a combination of importin
and Ran-GTP systems.
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